Compliance Corner: Here’s How Stryker Decides Whether To Launch A Device Recall
Executive Summary
Stryker Corp. regulatory expert Ommeed Shahrokh explains the device giant’s decision-making process around product recalls and describes what’s included in recall letters to customers.
You may also be interested in...
Device Giants Stryker And Baxter Embrace A ‘Quality First’ Culture – And Yield Positive Results
From cutting costs to getting products to market faster, experts at the two companies explain why it pays to keep quality at the fore.
Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
Thumbs Up: FDA Authorizes Weight Loss Suturing Systems From Apollo Endosurgery
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.